Study: oral vapitadine cuts itch without sedation.(News)
SAN ANTONIO -- An oral formulation of the investigational drug vapitadine was found to be more effective than placebo in providing itch relief to patients with atopic dermatitis in a recent phase II study.
The drug, an [H.sub.1] antihistamine, also did not produce any sedative effects--a common criticism of other such itch-relief medications--according to the results of a randomized controlled trial presented at the annual meeting of the American Academy of Dermatology.
Braham Shroot, Ph.D., chief scientific officer of Barrier Therapeutics Inc., reported the results in a poster session on behalf of Dr. J.M. Naeyaert of the department of dermatology at the …
Related articles on HighBeam Research
Chain Drug Review; May 1, 2006
Drug Utilization Review; May 1, 2003
CCNMatthews Newswire; March 8, 2007
CCNMatthews Newswire; August 23, 2006
Biotech Week; August 20, 2008
Publication Finder
Browse back issues from our extensive library of more than 6,500 trusted publications.
Popular publicationson HighBeam Research
Help us improve our websites
Become a member of our Customer Advisory Panel. Your opinion matters!
Join the panel